These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25816425)

  • 21. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
    Bhathena RK
    J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E
    Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.
    Shi D; Dyck MK; Uwiera RR; Russell JC; Proctor SD; Vine DF
    Endocrinology; 2009 Sep; 150(9):4425-36. PubMed ID: 19470707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overweight and obesity in youth in schools-the role of the school nurse: position statement.
    NASN Sch Nurse; 2014 May; 29(3):152-3. PubMed ID: 24937904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification.
    Cruz ML; Shaibi GQ; Weigensberg MJ; Spruijt-Metz D; Ball GD; Goran MI
    Annu Rev Nutr; 2005; 25():435-68. PubMed ID: 16011474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic profile in sons of women with polycystic ovary syndrome.
    Recabarren SE; Smith R; Rios R; Maliqueo M; Echiburú B; Codner E; Cassorla F; Rojas P; Sir-Petermann T
    J Clin Endocrinol Metab; 2008 May; 93(5):1820-6. PubMed ID: 18230657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.
    Cruz ML; Weigensberg MJ; Huang TT; Ball G; Shaibi GQ; Goran MI
    J Clin Endocrinol Metab; 2004 Jan; 89(1):108-13. PubMed ID: 14715836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.
    Huang G; Coviello A
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):512-9. PubMed ID: 23108199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
    Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
    Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood obesity and insulin-resistant syndrome.
    Yensel CS; Preud'homme D; Curry DM
    J Pediatr Nurs; 2004 Aug; 19(4):238-46. PubMed ID: 15308973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and overweight-obese women with polycystic ovary syndrome.
    Bhattacharya SM
    Gynecol Endocrinol; 2010 May; 26(5):344-7. PubMed ID: 19903118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.
    Barfield E; Liu YH; Kessler M; Pawelczak M; David R; Shah B
    J Pediatr Adolesc Gynecol; 2009 Oct; 22(5):318-22. PubMed ID: 19576817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polycystic ovary syndrome in obese or type 1 diabetic (T1D) adolescent girls].
    Bouthors T; Elowe-Gruau É; Antoniou MC; Hryciuk J; Stoppa-Vaucher S; Ruiz Arana IL; Diserens C; Busiah K; Hauschild M
    Rev Med Suisse; 2020 Oct; 16(710):1941-1944. PubMed ID: 33058582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.